Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma
Cancers · 13.10.2023 · 15 (20) · 4977
DOI: 10.3390/cancers15204977 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 13.10.2023. Verfasst von Aloña Agirre-Lizaso und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver and Gastrointestinal Diseases, Biodonostia Research Institute, Donostia University Hospital, University of the Basque Country (UP…. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spanish Carlos III Health Institute, Scientific Foundation of the Spanish Association Against Cancer, Fondo Europeo de Desarrollo Regional.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is a prevalent and aggressive cancer that comprises a complex tumour microenvironment (TME). Tumour-associated macrophages (TAMs) are one of the most abundant immune cells present in the TME, and play a key role both in the development and in the progression of HCC. Thus, TAM-based immunotherapy has been presented as a promising strategy to complement the currently available therapies for HCC treatment. Among the novel approaches focusing on TAMs, reprogramming their functional state has emerged as a promising option for targeting TAMs as an immunotherapy in combination with the currently available treatment options. Nevertheless, a further understanding of the immunobiology of TAMs is still required. This review synthesizes current insights into the heterogeneous nature of TAMs in HCC and describes the mechanisms behind their pro-tumoural polarization focusing the attention on their interaction with HCC cells. Furthermore, this review underscores the potential involvement of TAMs’ reprogramming in HCC therapy and highlights the urgency of advancing our understanding of these cells within the dynamic landscape of HCC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Liver and Gastrointestinal Diseases, Biodonostia Research Institute, Donostia University Hospital, University of the Basque Country (UPV-EHU), 20014 Donostia-San Sebastian, Spain.
- Centre for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
- IKERBASQUE, Basque Foundation for Science, 48009 Bilbao, Spain.
- Department of Biochemistry and Genetics, School of Sciences, University of Navarra, 31008 Pamplona, Spain.
- Department of Medicine, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 20014 Donostia-San Sebastian, Spain.
ORCID-Profile: Aloña Agirre-Lizaso, Pedro M Rodrigues
Förderung
- Spanish Carlos III Health Institute
- Scientific Foundation of the Spanish Association Against Cancer
- Fondo Europeo de Desarrollo Regional
Zitieren
APA
Agirre-Lizaso, A., Huici-Izagirre, M., Urretabizkaia-Garmendia, J., Rodrigues, P. M., Banales, J. M., & Perugorria, M. J. (2023). Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma. Cancers, 15(20), 4977. https://doi.org/10.3390/cancers15204977
Vancouver
Agirre-Lizaso A, Huici-Izagirre M, Urretabizkaia-Garmendia J, Rodrigues PM, Banales JM, Perugorria MJ. Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma. Cancers. 2023;15(20):4977. doi:10.3390/cancers15204977
BibTeX
@article{AgirreLizaso2023,
author = {Agirre-Lizaso, Aloña and Huici-Izagirre, Maider and Urretabizkaia-Garmendia, Josu and Rodrigues, Pedro M and Banales, Jesus M and Perugorria, Maria J},
title = {Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma},
journal = {Cancers},
year = {2023},
volume = {15},
number = {20},
pages = {4977},
doi = {10.3390/cancers15204977}
}
EUVIMED